Roep BO - Search Results

1

Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation.

Nikolic T, Woittiez NJC, van der Slik A, Laban S, Joosten A, Gysemans C, Mathieu C, Zwaginga JJ, Koeleman B, Roep BO. Nikolic T, et al. Among authors: roep bo. Genes Immun. 2017 Sep;18(3):176-183. doi: 10.1038/gene.2017.18. Epub 2017 Aug 10. Genes Immun. 2017. PMID: 28794505

2

HLA class II associations with Type 1 diabetes mellitus: a multivariate approach.

Schipper RF, Koeleman BP, Bruining GJ, Schreuder GM, Verduijn W, De Vries RR, Roep BO. Schipper RF, et al. Among authors: roep bo. Tissue Antigens. 2001 Feb;57(2):144-50. doi: 10.1034/j.1399-0039.2001.057002144.x. Tissue Antigens. 2001. PMID: 11260509

3

Seasonality of birth in patients with type 1 diabetes.

Koeleman BP, Valdigem G, Eerligh P, Giphart MJ, Roep BO. Koeleman BP, et al. Among authors: roep bo. Lancet. 2002 Apr 6;359(9313):1246-7; author reply 1247-8. doi: 10.1016/S0140-6736(02)08228-4. Lancet. 2002. PMID: 11955562 No abstract available.

4

Association between D6S2223 and type I diabetes independent of HLA class II in Dutch families.

Koeleman BV, De Groot KN, Van Der Slik AR, Roep BO, Giphart MJ. Koeleman BV, et al. Among authors: roep bo. Diabetologia. 2002 Apr;45(4):598-9. doi: 10.1007/s00125-001-0725-1. Diabetologia. 2002. PMID: 12032641 No abstract available.

5

Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3).

van Halteren AG, van Etten E, de Jong EC, Bouillon R, Roep BO, Mathieu C. van Halteren AG, et al. Among authors: roep bo. Diabetes. 2002 Jul;51(7):2119-25. doi: 10.2337/diabetes.51.7.2119. Diabetes. 2002. PMID: 12086941

6

Susceptibility loci for complex regional pain syndrome.

van de Beek WJ, Roep BO, van der Slik AR, Giphart MJ, van Hilten BJ. van de Beek WJ, et al. Among authors: roep bo. Pain. 2003 May;103(1-2):93-7. doi: 10.1016/s0304-3959(02)00444-x. Pain. 2003. PMID: 12749963

7

KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.

van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. van der Slik AR, et al. Among authors: roep bo. Diabetes. 2003 Oct;52(10):2639-42. doi: 10.2337/diabetes.52.10.2639. Diabetes. 2003. PMID: 14514651

8

Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes.

Eerligh P, Koeleman BP, Dudbridge F, Jan Bruining G, Roep BO, Giphart MJ. Eerligh P, et al. Among authors: roep bo. Genes Immun. 2004 Jan;5(1):36-40. doi: 10.1038/sj.gene.6364036. Genes Immun. 2004. PMID: 14735147

9

Insulin-like growth factor 1 promoter polymorphism influences insulin gene variable number of tandem repeat-associated risk for juvenile onset type 1 diabetes.

Eerligh P, Roep BO, Giphart MJ, Koeleman BP. Eerligh P, et al. Among authors: roep bo. Tissue Antigens. 2004 Jun;63(6):568-71. doi: 10.1111/j.0001-2815.2004.00229.x. Tissue Antigens. 2004. PMID: 15140033

10

Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease.

Koeleman BP, Lie BA, Undlien DE, Dudbridge F, Thorsby E, de Vries RR, Cucca F, Roep BO, Giphart MJ, Todd JA. Koeleman BP, et al. Among authors: roep bo. Genes Immun. 2004 Aug;5(5):381-8. doi: 10.1038/sj.gene.6364106. Genes Immun. 2004. PMID: 15164102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters